Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse TranscriptaseChristal D. Sohl, Karen S. Anderson|Molecular Pharmacology|2012Cited by 16
Catalytically distinct IDH1 mutants tune phenotype severity in tumor modelsMowaffaq Adam Ahmed Adam, Christal D. Sohl|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0